Press Releases


Taconic Biosciences Launches New Tagline, Celebrating Commitment to Customers and the Microbiome

Hudson, NY — October 6, 2017 - Taconic Biosciences, a global leader in genetically engineered rodent models and associated services, announces the launch of a new tagline: "Models For Life™." Introducing a fresh interpretation of Taconic's brand and 65 year history, the new tagline celebrates Taconic's unparalleled commitment to its customers and industry leading microbiome products and services. The new 'Models For Life' tagline sits at the...

Read More

Taconic Biosiences Sponsors Custom Model to Support Kabuki Syndrome, a Rare Disorder Causing Intellectual Disability

Hudson, NY — August 31, 2017 - Taconic Biosciences, a global leader in genetically engineered rodent models and associated services, is funding the development of a custom mouse model to study Kabuki syndrome, a rare genetic disorder. Taconic is donating model generation services as a third-time sponsor of the Rare Disease Science Challenge, BeHEARD. Hosted by the Rare Genomics Institute, the Rare Disease Science Challenge is an...

Read More

Taconic Biosciences Plans to Relocate Headquarters to Albany, NY Area

Hudson, NY — August 23, 2017 - Taconic Biosciences announces plans to move its corporate headquarters up the Hudson River from Hudson to the Albany, NY area at the end of 2017. The new location is near several existing Taconic facilities in Rensselaer, 45 miles from its primary operations facility in Germantown, NY, and accessible to all global locations. With Taconic's increasing prominence within the global pharmaceutical...

Read More

Taconic Biosciences Announces Partnership with Cergentis B.V. to Provide Transgene Mapping Services

Hudson, NY — August 8, 2017 - Taconic Biosciences, a global leader in genetically engineered mouse models and associated services, announced it has signed a collaborative agreement with Cergentis B.V. ("Cergentis") to leverage the company's Targeted Locus Amplification (TLA) technology to provide transgene mapping services to its customers. While transgenic mice generated via random pro-nuclear injection (PNI) continue to be a critical tool in biomedical research, a...

Read More

Taconic Biosciences and Pharmatest Services LTD Create First Human Immune System Model for Bone Metastasis

Researchers hopeful this new model will address incurable and painful disease Hudson, NY — July 5, 2017 - Taconic Biosciences, a global leader in genetically engineered mouse models and associated services, announced it has signed a collaborative agreement with Pharmatest Services, Ltd. ("Pharmatest") to leverage the company's oncology and skeletal disease preclinical efficacy services using Taconic's humanized mouse models. Bone metastasis develops when cancer spreads from elsewhere...

Read More

Mice in Space: Taconic Mice Included on Launch to International Space Station

Hudson, NY — June 1, 2017 - When the SpaceX Dragon spacecraft launches today bound for the International Space Station, they will be joined by 40 special mice, bred specifically for this mission by Taconic Biosciences, a global leader in genetically engineered mouse models and associated services. The project is a collaboration between the University of California, Los Angeles (UCLA), the Center for the Advancement of Science...

Read More

Taconic Biosciences Secures CRISPR License from ERS Genomics

Hudson, NY — May 30, 2017 - Taconic Biosciences, a global leader in genetically engineered mouse models and associated services, announced it has signed a license agreement with ERS Genomics ("ERS") to utilize the company's CRISPR-Cas9 technology to generate unique murine models. Under the agreement, Taconic receives a worldwide non-exclusive license to the CRISPR-Cas9 patents often referred to as the "UC Berkeley patent." ERS Genomics founder, Emmanuelle...

Read More

Taconic Biosciences Expands Microbiome Portfolio

Germ Free BALB/c Mice Facilitate Discovery of New Therapeutics Hudson, NY — May 4, 2017 - Taconic Biosciences, global leader in genetically engineered mouse models and associated services and the only commercial provider of germ-free mice, announced it has added Germ Free BALB/c mice to its microbiome portfolio. The new product expands Taconic's existing collection of germ-free animal models, which includes C57BL/6 (Black 6) and Swiss Webster...

Read More

Taconic Biosciences Announces Expansion of Key Alzheimer Animal Model

Hudson, NY — May 3, 2017 - Taconic Biosciences, a global leader in genetically engineered mouse models and associated services, announced it will expand the offering of a key Alzheimer's Disease (AD) mouse model, APPSWE - Model 1349, to include aged animals. Taconic will now offer off-the-shelf Model 1349 animals aged up to 42 weeks, saving months off the typical timeline to access Alzheimer's models. This program...

Read More

Taconic Biosciences Expands Microbiome Product and Service Platform

Hudson, NY — April 26, 2017 - Taconic Biosciences, a global leader in genetically engineered mouse models and associated services and the only commercial provider of germ-free mice, announced that effective April 26, 2017 they will expand their microbiome product and services platform to include custom Fecal Microbiota Transplantation (FMT) services. To support these new FMT services, Taconic will also offer custom germ-free derivations using either client...

Read More